18-Nov-2026 17:02:03
PPLPHARMA : TO ACQUIRE BALANCE 26% STAKE IN YAPAN BIO
• Administrative Committee of the Board approved exercise of the company's call option to buy the balance 26% equity stake in Yapan Bio from existing sharehold…
Latest market headlines for PPLPHARMA on Terminal.
18-Nov-2026 17:02:03
• Administrative Committee of the Board approved exercise of the company's call option to buy the balance 26% equity stake in Yapan Bio from existing sharehold…
17-Nov-2026 15:01:26
PIRAMAL PHARMA: Carlyle likely To Sell Entire stake in Piramal Pharma VIA BLOCK deal Soon - NDTV PROFIT
29-Oct-2026 10:46:27
• Management upgraded its FY27 revenue growth outlook to approximately 19–20%, supported by strong H1 performance, healthy CDMO demand and growth in Complex Ho…
28-Oct-2026 13:51:30
PIRAMAL PHARMA says Onboarded 22 New Clients Last Quarter
28-Oct-2026 13:51:06
PIRAMAL PHARMA Says Most Of Our New Customers Are In The CDMO Space | Worked Hard On Order Inflows & RFPS To Ensure Broad-Based Growth
28-Oct-2026 13:49:44
PIRAMAL PHARMA says Operating Leverage Will Aid, Margin To Improve Hereon
28-Oct-2026 12:43:27
PIRAMAL PHARMA says H2 Revenue Growth To Be Stronger Than Q1
27-Oct-2026 21:20:35
PIRAMAL PHARMA Q2 ; UPGRADES FY27 REVENUE GROWTH GUIDANCE TO 19-20 % FROM EARLIER EARLY-TO-MID TEEN GROWTH 🟢🟢
27-Oct-2026 21:18:55
We are therefore raising our FY27 outlook and now anticipate 19-20% revenue growth with meaningfully higher profitability.
27-Oct-2026 21:14:22
REVENUE UP 28.05% AT ₹2,617.06 CR (YOY), UP 15.29% (QOQ) EBITDA UP 119.76% AT ₹348.74 CR (YOY), UP 78.66% (QOQ) MARGINS AT 13.33% VS 7.76% (YOY), 8.60% (QOQ)
01-Oct-2026 20:12:06
• Commercial arrangement for sales and distribution support services with Bayer Pharmaceuticals Private Limited to expire on December 31, 2026 • Arrangement wi…
01-Oct-2026 19:05:36
• Piramal Pharma’s Aurora facility received funding from the Government of Ontario under the Life Sciences Scale-Up Fund (LSSUF) program. • The funding will su…
30-Sept-2026 20:10:22
• Mr. Viral Gandhi appointed as Chief Technology Officer and Senior Management Personnel • Appointment effective from October 1, 2026 • Mr. Gandhi has over two…
30-Sept-2026 17:58:13
• Mr. Jeffrey Hampton, President and COO, Piramal Critical Care, to retire from services of the Company effective close of business hours on 27th November, 202…
29-Sept-2026 10:59:30
• Company received an Order-in-Original on September 28, 2026, from Additional Commissioner, CGST & Central Excise, Mumbai East Commissionerate, concerning GST…
14-Sept-2026 19:52:32
PIRAMAL PHARMA LIMITED : US FDA INSPECTION AT MORPETH FACILITY YIELDS 7 OBSERVATIONS
18-Aug-2026 11:39:21
• Piramal Pharma Limited has completed the acquisition of 1,46,400 equity shares of ₹10 each of Yapan Bio Private Limited for approximately ₹76 crores. • The a…
09-Jul-2026 10:59:07
• Piramal Pharma Limited's manufacturing facility at Sellersville (USA) has successfully closed its US FDA inspection. • The US FDA has issued an Establishment…
29-Jun-2026 19:46:51
• Promoters or Promoter Group have not made any encumbrance, directly or indirectly, on the shares / securities of Piramal Pharma Limited during the financial…